Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7290-7295
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7290
Table 1 General conditions of the three patients with liver tumor
No.SexAge (yr)DiseaseSegments involvedTumor diameter(cm)Vessels involvedor infiltrated
1Female60Hemangioma1, 4, 5, 6, 7, 820IVC (circum 190°, length 5 cm)
2Male64Cholangiocarcinoma1, 2, 3, 46IVC (circum 80°, length 3 cm)
3Male55Cholangiocarcinoma1, 5, 7, 85IVC (circum 60°, length 2 cm)
RHV, MHV, RPV
Table 2 Details of ex-situ hepatectomy without venous bypass in the three patients
No.HepatectomySegments resectedIVC reconstructionOperation time (h)Anhepatic phase (h)Blood loss (mL)ComplicationHospital stay (d)Outcome
1Ex vivo hepatectomy with reimplantation of segment 2 and 31, 4, 5, 6, 7, 8Synthetic graft and autologous IVC6.63.81200Pleural effusion28Alive without disease 22 mo after operation
2Ex vivo hepatectomy with reimplantation of segment 4b, 5, 6, 7, 81, 2, 3, 4Synthetic graft6.42.83100No38Alive without disease 17 mo after operation
3Ex vivo hepatectomy with reimplantation of segment 2, 3, 41, 5, 6, 7, 8Synthetic graft7.34.02000Liver and renal failure11Died
Table 3 Difference of operation time and anhepatic phase between our study and Pichlmayr’s venous bypass group
nOperation time (h)Anhepatic phase (h)Postoperativedeath
Pichlmayr’s913.7 ± 2.65.7 ± 1.73
 (11-18)  (4-9)
Present series36.7 ± 0.473.5 ± 0.641
 (6.4-7.3)  (2.8-4.0)